Jasper Therapeutics Inc (NASDAQ: JSPR) on Tuesday, plunged -4.61% from the previous trading day, before settling in for the closing price of $3.47. Within the past 52 weeks, JSPR’s price has moved between $2.27 and $26.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 54.53% annually for the last half of the decade. The company achieved an average annual earnings per share of 9.44%. With a float of $12.59 million, this company’s outstanding shares have now reached $15.02 million.
In an organization with 64 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 24.53%, operating margin of -7067.21%, and the pretax margin is 1169.34%.
Jasper Therapeutics Inc (JSPR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Jasper Therapeutics Inc is 16.21%, while institutional ownership is 75.66%. The most recent insider transaction that took place on Dec 12 ’24, was worth 19,899. In this transaction Chief Operating Officer of this company sold 900 shares at a rate of $22.11, taking the stock ownership to the 25,009 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Executive Officer proposed sale 900 for $22.47, making the entire transaction worth $20,223.
Jasper Therapeutics Inc (JSPR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 9.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.38% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Jasper Therapeutics Inc (JSPR) is currently performing well based on its current performance indicators. A quick ratio of 4.31 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.25, a number that is poised to hit -1.33 in the next quarter and is forecasted to reach -3.65 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.41 million. That was better than the volume of 0.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.65%.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 21.22%, which indicates a significant increase from 21.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was higher than the 0.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.07, while its 200-day Moving Average is $10.77. However, in the short run, Jasper Therapeutics Inc’s stock first resistance to watch stands at $3.49. Second resistance stands at $3.67. The third major resistance level sits at $3.81. If the price goes on to break the first support level at $3.17, it is likely to go to the next support level at $3.03. Assuming the price breaks the second support level, the third support level stands at $2.85.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
Market capitalization of the company is 49.73 million based on 15,022K outstanding shares. Right now, sales total 0 K and income totals -71,270 K. The company made 0 K in profit during its latest quarter, and -21,240 K in sales during its previous quarter.
